acivicin has been researched along with Acute Promyelocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mason, SN; Weinberg, JB; Wortham, TS | 1 |
| Chitneni, SR; Moore, JO; Nichols, KE; Weinberg, JB | 1 |
2 other study(ies) available for acivicin and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) messenger RNA (mRNA) expression in HL-60 leukemia cells by pentoxifylline and dexamethasone: dissociation of acivicin-induced TNF-alpha and IL-1 beta mRNA expression
Topics: Cell Differentiation; Dexamethasone; Esterases; Gene Expression; Genes, myc; Humans; Hydrogen Peroxide; Interleukin-1; Isoxazoles; Leukemia, Promyelocytic, Acute; Pentoxifylline; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-myb; RNA, Messenger; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1992 |
Monocytoid differentiation of freshly isolated human myeloid leukemia cells and HL-60 cells induced by the glutamine antagonist acivicin.
Topics: Antibiotics, Antineoplastic; Cell Differentiation; Cell Division; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Isoxazoles; Kinetics; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Leukocytes; Oxazoles; Reference Values; Tumor Cells, Cultured | 1989 |